# data[].attributes.body
Alice (Achiever)- Alice would be a vital asset to the team as she is a natural hard worker. Her ability to lead by example would propel the rest of the team to succeed.
Faith (Futuristic)- Faith would inspire the team to see a vision for our product. She would be the visionary for our team.
Ivan (intellection)- Ivan would help the team to think intellectually. Further allowing the team to think outside the box and clearly.
Susan (significance)- Susan would help our product to become recognized by others.
William (Woo)- William's ability to communicate with new people would help the team to build connections with investors.

# data[].attributes.body
Hastings, C. (2020, December 11). Mitochondrial Transplantation to Treat Ischemia-Reperfusion Injury: Interview with Dr. Alexander Schueller, CEO of cellvie |. Medgadget. https://www.medgadget.com/2020/12/mitochondrial-transplantation-to-treat-ischemia-reperfusion-injury-interview-with-dr-alexander-schueller-ceo-of-cellvie.html

# data[].attributes.body
Pros
-Noninvasive treatment delivery with catheters and syringes.
-Better long-term outcomes for patients with Ischemic reperfusion injury.
-The mitochondria are prepared in an automated system.

Cons
-Treatment is still in the beginning stages of development with a current pilot study on animals.
- The treatment has not been completed on humans yet.
-The first product will be produced on the market in 2026.

# data[].attributes.body
Many of us have heard the phrase "time is tissue." I believe that this initiative treatment will allow patients with ischemic injuries the time needed to perfuse the affected tissue. The World Health Organization (2020) identified ischemic heart disease as the leading cause of death in the world. As an ICU nurse, I have experienced firsthand the catastrophic events that occur for patients who have had a heart attack or stroke. Currently, there is not much that can be done to provide quick reperfusion to patients with irreversible ischemic injuries.

# data[].attributes.body
Ischemic injuries can cause traumatic injuries to the brain, heart, and other vital organs. A company based out of Houston is creating a therapy for mitochondrial transplantation to decrease the harmful effects of ischemia-reperfusion injury. Individual isolated mitochondrial cells are delivered to the ischemic area to disrupt the catabolism that causes cell death. Alexander Schueller (2020), explains that when there is an interference in blood flow the affected cell no longer receives the oxygen needed to produce sufficient energy, therefore causing the affected cell to function improperly. Mitochondrial transplantation therapy was invented to improve outcomes in patients who have had an organ transplant with graft function specifically heart and kidney transplants and for patients who have experienced an MI or ischemic stroke (Hastings, 2020).

# data[].attributes.body
https://www.youtube.com/watch?v=VC-anBpXoX4

# data[].attributes.attachment_link.title
Cellvie - MedTech Innovator Best Video Competition